Published in J Stroke Cerebrovasc Dis on March 29, 2013
A comprehensive stroke center patient registry: advantages, limitations, and lessons learned. Med Student Res J (2013) 1.01
Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes. Stroke Res Treat (2016) 0.79
Early Neurologic Deterioration after Stroke Depends on Vascular Territory and Stroke Etiology. J Stroke (2016) 0.78
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72
LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62
Cerebral ischemia and atrial fibrillation: prospective study. Neurology (1984) 1.09
Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome. Am Heart J (2008) 0.88
No consensus on definition criteria for stroke registry common data elements. Cerebrovasc Dis Extra (2011) 0.88
Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction. Mediators Inflamm (2009) 0.85
Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke. Cerebrovasc Dis (2012) 0.79
A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS (2010) 1.81
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke (2006) 1.70
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62
Inpatient rehabilitation centers and concern for increasing volume of ischemic stroke patients requiring rehabilitation. South Med J (2013) 1.60
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59
What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke? J Stroke Cerebrovasc Dis (2012) 1.48
The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours. Stroke (2008) 1.43
Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovasc Dis (2008) 1.39
Prevalence of atherosclerotic plaque in young and middle-aged asymptomatic individuals: the Bogalusa heart study. South Med J (2011) 1.39
Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke (2014) 1.39
Thrombolytic therapy for patients who wake-up with stroke. Stroke (2009) 1.23
Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22
Intracerebral hemorrhage in cocaine users. Stroke (2010) 1.20
Disparities in evaluation at certified primary stroke centers: reasons for geographic and racial differences in stroke. Stroke (2013) 1.11
Early Neurological Deterioration (END) after stroke: the END depends on the definition. Int J Stroke (2011) 1.09
Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke (2013) 1.07
Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med (2010) 1.06
Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav (2011) 1.05
Manual and automated measurement of the whole thalamus and mediodorsal nucleus using magnetic resonance imaging. Neuroimage (2002) 1.02
Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis (2012) 1.02
Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis (2012) 1.02
Comprehensive stroke centers and the 'weekend effect': the SPOTRIAS experience. Cerebrovasc Dis (2012) 1.02
Velocity criteria for intracranial stenosis revisited: an international multicenter study of transcranial Doppler and digital subtraction angiography. Stroke (2011) 1.01
Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke (2008) 1.00
Using telemedicine to facilitate thrombolytic therapy for patients with acute stroke. Jt Comm J Qual Patient Saf (2006) 0.99
Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state. Clin Appl Thromb Hemost (2013) 0.96
Daily National Institutes of Health Stroke Scale examinations at stroke centers: why not do them? Int J Stroke (2015) 0.94
A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis (2013) 0.93
Emergency department shift change is associated with pneumonia in patients with acute ischemic stroke. Stroke (2011) 0.91
Ethnic disparities trump other risk factors in determining delay to emergency department arrival in acute ischemic stroke. Ethn Dis (2013) 0.90
Circulating adipocytokines and chronic kidney disease. PLoS One (2013) 0.89
Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients. J Stroke Cerebrovasc Dis (2013) 0.89
No consensus on definition criteria for stroke registry common data elements. Cerebrovasc Dis Extra (2011) 0.88
New model for predicting surgical feeding tube placement in patients with an acute stroke event. Stroke (2013) 0.86
Intravenous tissue plasminogen activator in patients with cocaine-associated acute ischemic stroke. Stroke (2009) 0.86
Circle of Willis Variants: Fetal PCA. Stroke Res Treat (2013) 0.85
Loperamide Versus Psyllium Fiber for Treatment of Fecal Incontinence: The Fecal Incontinence Prescription (Rx) Management (FIRM) Randomized Clinical Trial. Dis Colon Rectum (2015) 0.84
Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptor. J Comp Neurol (2007) 0.82
Association of sleep apnea with clinically silent microvascular brain tissue changes in acute cerebral ischemia. J Neurol (2013) 0.82
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. J Neurooncol (2015) 0.82
Nadir hemoglobin is associated with poor outcome from intracerebral hemorrhage. Springerplus (2013) 0.81
Changing demographics at a comprehensive stroke center amidst the rise in primary stroke centers. Stroke (2013) 0.81
Family history of stroke among African Americans and its association with risk factors, knowledge, perceptions, and exercise. J Cardiovasc Nurs (2015) 0.81
Comment on US geographic distribution of recombinant tissue plasminogen activator use by hospitals for acute ischemic stroke. Stroke (2010) 0.81
Computed tomography perfusion prognostic maps do not predict reversible and irreversible neurological dysfunction following reperfusion therapies. Int J Stroke (2011) 0.80
Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome. Stroke (2013) 0.80
Prioritizing Paperwork Over Patient Care: Why Can't We Do Both? J Grad Med Educ (2015) 0.80
Racial disparities in early mortality in 1,134 young patients with acute stroke. Neurol Sci (2014) 0.80
Blood pressure in acute stroke: lower it or let the CHHIPS fall where they will. Lancet Neurol (2008) 0.79
Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Clin Infect Dis (2005) 0.79
Geographic access to US Neurocritical Care Units registered with the Neurocritical Care Society. Neurocrit Care (2012) 0.79
Early sleep apnea screening on a stroke unit is feasible in patients with acute cerebral ischemia. J Neurol (2012) 0.78
Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex. Stroke (2013) 0.78
The NIHSS Score and its Components can Predict Cortical Stroke. J Neurol Disord Stroke (2013) 0.77
Perfect Storm of Inpatient Communication Needs and an Innovative Solution Utilizing Smartphones and Secured Messaging. Appl Clin Inform (2016) 0.77
Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental area. J Comp Neurol (2002) 0.77